Aromatase inhibitor withdrawal response in metastatic breast cancer.
Cigler
Tessa
T
Massachusetts General Hospital, Boston, MA, USA.
Goss
Paul E
PE
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D005260:Female; D017273:Goserelin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D017697:Premenopause
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin